These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9683835)
1. Magnetic resonance spectroscopy study of low grade extra and intracerebral human neoplasms. Tugnoli V; Tosi MR; Barbarella G; Ricci R; Leonardi M; Calbucci F; Bertoluzza A Oncol Rep; 1998; 5(5):1199-203. PubMed ID: 9683835 [TBL] [Abstract][Full Text] [Related]
2. Malignancy of brain tumors evaluated by proton magnetic resonance spectroscopy (1H-MRS) in vitro. Czernicki Z; Horsztyński D; Jankowski W; Grieb P; Walecki J Acta Neurochir Suppl; 2000; 76():17-20. PubMed ID: 11449999 [TBL] [Abstract][Full Text] [Related]
3. Cholesteryl esters in human malignant neoplasms. Tosi MR; Bottura G; Lucchi P; Reggiani A; Trinchero A; Tugnoli V Int J Mol Med; 2003 Jan; 11(1):95-8. PubMed ID: 12469226 [TBL] [Abstract][Full Text] [Related]
4. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. Kinoshita Y; Yokota A NMR Biomed; 1997 Jan; 10(1):2-12. PubMed ID: 9251109 [TBL] [Abstract][Full Text] [Related]
5. Quantitative metabolite patterns of human brain tumors: detection by 1H NMR spectroscopy in vivo and in vitro. Usenius JP; Kauppinen RA; Vainio PA; Hernesniemi JA; Vapalahti MP; Paljärvi LA; Soimakallio S J Comput Assist Tomogr; 1994; 18(5):705-13. PubMed ID: 8089316 [TBL] [Abstract][Full Text] [Related]
6. In vivo hydrogen-1 magnetic resonance spectroscopy study of human intracranial tumors. Luan W; Zhang J Chin Med J (Engl); 1998 Jan; 111(1):56-8. PubMed ID: 10322655 [TBL] [Abstract][Full Text] [Related]
7. Non-invasive characterization of brain tumor by in-vivo proton magnetic resonance spectroscopy. Harada M; Tanouchi M; Nishitani H; Miyoshi H; Bandou K; Kannuki S Jpn J Cancer Res; 1995 Mar; 86(3):329-32. PubMed ID: 7744704 [TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors. Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance spectroscopy in intracranial tumours of glial origin. Jaskólski DJ; Fortuniak J; Majos A; Gajewicz W; Papierz W; Liberski PP; Sikorska B; Stefańczyk L Neurol Neurochir Pol; 2013; 47(5):438-49. PubMed ID: 24166565 [TBL] [Abstract][Full Text] [Related]
10. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cheng LL; Chang IW; Louis DN; Gonzalez RG Cancer Res; 1998 May; 58(9):1825-32. PubMed ID: 9581820 [TBL] [Abstract][Full Text] [Related]
11. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation. Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073 [TBL] [Abstract][Full Text] [Related]
12. Preoperative grading of intracranial meningioma by magnetic resonance spectroscopy (1H-MRS). Lin MC; Li CZ; Hsieh CC; Hong KT; Lin BJ; Lin C; Tsai WC; Lee CH; Lee MG; Chung TT; Tang CT; Ju DT; Ma HI; Liu MY; Chen YH; Hueng DY PLoS One; 2018; 13(11):e0207612. PubMed ID: 30452483 [TBL] [Abstract][Full Text] [Related]
13. The expression of hypoxia-inducible factor-1 in primary brain tumors. Reszec J; Rutkowski R; Chyczewski L Int J Neurosci; 2013 Sep; 123(9):657-62. PubMed ID: 23550771 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy. Yerli H; Ağildere AM; Ozen O; Geyik E; Atalay B; Elhan AH Diagn Interv Radiol; 2007 Mar; 13(1):3-9. PubMed ID: 17354186 [TBL] [Abstract][Full Text] [Related]
15. Noninvasive evaluation of radiation-enhanced glioma cells invasiveness by ultra-high-field (1)H-MRS in vitro. Xu YJ; Cui Y; Li HX; Shi WQ; Li FY; Wang JZ; Zeng QS Magn Reson Imaging; 2016 Oct; 34(8):1121-7. PubMed ID: 27215950 [TBL] [Abstract][Full Text] [Related]
16. Potential of MR spectroscopy for assessment of glioma grading. Bulik M; Jancalek R; Vanicek J; Skoch A; Mechl M Clin Neurol Neurosurg; 2013 Feb; 115(2):146-53. PubMed ID: 23237636 [TBL] [Abstract][Full Text] [Related]
17. Unique magnetic resonance spectroscopy profile of intracranial meningiomas compared to gliomas: a systematic review. De Stefano FA; Morell AA; Smith G; Warner T; Soldozy S; Elarjani T; Eichberg DG; Luther E; Komotar RJ Acta Neurol Belg; 2023 Dec; 123(6):2077-2084. PubMed ID: 36595196 [TBL] [Abstract][Full Text] [Related]
18. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes. Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081 [TBL] [Abstract][Full Text] [Related]
19. Differential diagnosis of intracranial meningiomas based on magnetic resonance spectroscopy. Jaskólski DJ; Fortuniak J; Stefańczyk L; Majos A; Gajewicz W; Papierz W; Liberski PP; Sikorska B Neurol Neurochir Pol; 2013; 47(3):247-55. PubMed ID: 23821422 [TBL] [Abstract][Full Text] [Related]
20. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]